Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Extension of Period of Validity for Site Licenses

Mar 7, 2021

If you have a Site License set to expire by March 31, 2021, the NNHPD is providing an extension for the site license period of validity until June 01, 2021. This is due to license renewal delays resulting from the COVID-19 pandemic. The extension is applicable to...

Face Masks – Innovation and Opportunity

Feb 5, 2021

It is hard to imagine that just one year ago we were shopping and eating in restaurants without fear and without face coverings. Since then, the use of facemasks and face shields has become commonplace even to the point that we feel naked without them when out in...

Interferon Beta 1a: Potentially Promising Treatment for Covid-19

Jan 20, 2021

A recent clinical trial reported in The Lancet Respiratory Medicine shows that the protein Interferon Beta 1a when inhaled, reduces the chances of hospitalized early-stage Covid-19 patients becoming severely ill or dying. The investigators conducted a randomized,...

The Sunshine Vitamin: What, Where, and How Much?

Nov 17, 2020

When the majority of people hear the term Vitamin D, they will immediately associate it with images of sunshine, warm climates, and the summer season. That is to say, many people are aware of the essential vitamin and our primary source of obtaining it, but: what...

A Risk-Based Approach to Site License Applications

Nov 13, 2020

In attempt to eliminate the recent issue of site license renewal backlogs, the Natural and Non-Prescription Health Products Directorate (NNHPD) is implementing a new risk based approach to the site license application. With an ambitious goal of removing all backlog by...

COVID-19 and Vitamin D: Correlation or Coincidence?

Nov 3, 2020

The past several months have unquestionably been inundated with what sometimes feels like constant streams of new information and theories surrounding the global virus, COVID-19. Some of the most thought-provoking of which concern a potential correlation between...

New Canadian Cosmetic Ingredient Hotlist Updates

Oct 22, 2020

Earlier this month, Health Canada released a new list of proposed updates to the Cosmetic Ingredient Hotlist, which included new additions, as well as revisions, to both the restricted and prohibited cosmetic ingredient lists. The proposed new additions to the...

New Cosmetic Ingredient Restrictions in the State of California

Oct 9, 2020

This month two new bills were signed by the Governor of California, implementing new restrictions on cosmetic ingredients within the state. The first of these bills, titled AB-2762 (Cosmetic Products: Safety), includes a list of twelve substances, including Dibutyl...

The Safety and Efficacy of Hand Sanitizers Against COVID-19

Aug 27, 2020

I) Introduction As the COVID-19 pandemic of 2020 continues to increase the demand for hand sanitizer, it is useful to understand how different hand sanitizers work and their properties. In this paper, we will explore alcohol and...

You and your Smart Phone Against Covid-19

Aug 26, 2020

We have previously reported on how smart phones, watches and their apps have the potential to aid in the health industry, such as the diagnosis of dementia or the sale of products. Therefore, it only makes sense that we use this technology to...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us